Fagron NV (EBR:FAGR)
Belgium · Delayed Price · Currency is EUR 22.35
-0.40 (-1.76%)
Mar 2, 2026, 2:21 PM CET
Fagron NV Market Cap
Fagron NV has a market cap or net worth of €1.67 billion as of March 2, 2026. Its market cap has increased by 13.70% in one year.
Market Cap
1.67B
Enterprise Value
1.96B
Revenue
952.17M
Ranking
n/a
PE Ratio
18.35
Stock Price
€22.35
Market Cap Chart
Since October 15, 2007, Fagron NV's market cap has increased from 312.17M to 1.67B, an increase of 433.77%. That is a compound annual growth rate of 9.54%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 27, 2026 | 1.67B | 6.81% |
| Dec 31, 2025 | 1.56B | 27.67% |
| Dec 31, 2024 | 1.22B | 0.73% |
| Dec 29, 2023 | 1.21B | 25.41% |
| Dec 30, 2022 | 967.24M | -10.30% |
| Dec 31, 2021 | 1.08B | -21.59% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| UCB SA | 48.03B |
| argenx SE | 40.23B |
| Financière de Tubize | 10.08B |
| Ion Beam Applications | 449.97M |
| Onward Medical | 235.24M |
| Hyloris Pharmaceuticals | 199.92M |
| Nyxoah | 160.49M |
| Sequana Medical NV | 40.71M |